Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of SU5416 and Interferon Alfa 2B in Unresectable or Metastatic Renal Cell Carcinoma

NCT00006384 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00006384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of SU5416 and Interferon Alfa 2B in Unresectable or Metastatic Renal Cell Carcinoma
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2000
Completion date
February 28, 2007
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer